Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.4 million.

  • Jaguar Health's Receivables - Net rose 1505.2% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 1505.2%. This contributed to the annual value of $1.5 million for FY2024, which is 2236.91% down from last year.
  • Jaguar Health's Receivables - Net amounted to $1.4 million in Q3 2025, which was up 1505.2% from $1.2 million recorded in Q2 2025.
  • Jaguar Health's Receivables - Net's 5-year high stood at $5.9 million during Q1 2021, with a 5-year trough of $987000.0 in Q1 2023.
  • For the 5-year period, Jaguar Health's Receivables - Net averaged around $1.9 million, with its median value being $1.5 million (2022).
  • In the last 5 years, Jaguar Health's Receivables - Net skyrocketed by 44450.6% in 2021 and then crashed by 6956.08% in 2022.
  • Quarter analysis of 5 years shows Jaguar Health's Receivables - Net stood at $1.7 million in 2021, then grew by 9.95% to $1.9 million in 2022, then increased by 4.68% to $2.0 million in 2023, then dropped by 22.37% to $1.5 million in 2024, then fell by 5.89% to $1.4 million in 2025.
  • Its Receivables - Net stands at $1.4 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.2 million for Q1 2025.